| Q35595377 | A prospective study of circulating mutant KRAS2 in the serum of patients with colorectal neoplasia: strong prognostic indicator in postoperative follow up. |
| Q36397389 | APC and K-ras gene mutation in aberrant crypt foci of human colon |
| Q38798435 | Advanced colorectal polyps with the molecular and morphological features of serrated polyps and adenomas: concept of a 'fusion' pathway to colorectal cancer |
| Q48309999 | Aging and the rise of somatic cancer-associated mutations in normal tissues |
| Q36540553 | Associations of Ki-ras proto-oncogene mutation and p53 gene overexpression in sporadic colorectal adenomas with demographic and clinicopathologic characteristics |
| Q38710117 | Biased competition between Lgr5 intestinal stem cells driven by oncogenic mutation induces clonal expansion. |
| Q37086263 | Clinicopathologic distribution of KRAS and BRAF mutations in a Chinese population with colorectal cancer precursor lesions |
| Q38973304 | Clonal evolution of colorectal cancer in IBD. |
| Q46087899 | HistoMosaic Detecting KRAS G12V Mutation Across Colorectal Cancer Tissue Slices through in Situ PCR. |
| Q38708005 | K-ras Mutations as the Earliest Driving Force in a Subset of Colorectal Carcinomas |
| Q40147512 | Mutational Heterogeneity in APC and KRAS Arises at the Crypt Level and Leads to Polyclonality in Early Colorectal Tumorigenesis |
| Q39306327 | New insights into the earliest stages of colorectal tumorigenesis |
| Q36280348 | Rechallenge and maintenance therapy using cetuximab and chemotherapy administered to a patient with metastatic colorectal cancer |
| Q38163598 | Rechallenge therapy and treatment holiday: different strategies in management of metastatic colorectal cancer. |
| Q38219625 | Stem cell dynamics in homeostasis and cancer of the intestine |
| Q39408419 | Subclonal diversity arises early even in small colorectal tumours and contributes to differential growth fates |
| Q37172151 | The genomics of colorectal cancer: state of the art. |
| Q34417549 | The presence of telomere fusion in sporadic colon cancer independently of disease stage, TP53/KRAS mutation status, mean telomere length, and telomerase activity |
| Q30995809 | Topographic analysis of K- ras mutations in histologically normal lung tissues and tumours of lung cancer patients |
| Q46393954 | Tumor-associated DNA mutation detection in individuals undergoing colonoscopy. |
| Q43500076 | Uptake of KRAS mutation testing in patients with metastatic colorectal cancer in Europe, Latin America and Asia |
| Q36619569 | c-Ki-ras mutations in colorectal adenocarcinomas from a country with a rapidly changing colorectal cancer incidence |